The new detector extends Evident's FLUOVIEW™FV5000 confocal platform, helping researchers capture fast-changing biological events simultaneously across up to four channels with data ready for quantitative analysis.
NEEDHAM, Mass., Nov. 13, 2026 /PRNewswire/ -- Evident today introduced its SilVIR-RAY™ detector technology for the FLUOVIEW™ FV5000 confocal laser scanning microscope, enabling neuroscience and cell biology researchers to capture up to four super-resolution channels simultaneously in a single scan. Evident will debut the detector during Neuroscience 2026, November 14–18 in Washington, D.C. at booth #1801.
In neuroscience and cell biology, many important questions depend on seeing how multiple molecules and structures interact at the same moment. Conventional super-resolution imaging often forces trade-offs between resolution, speed, and multicolor capture. Acquiring channels one after another also introduces time offsets, making it challenging to tell whether observed differences reflect true biological activity.
Developed by Evident's optical engineers with input from the life science research community, the SilVIR-RAY detector addresses these challenges by capturing up to four super-resolution channels simultaneously in a single acquisition, supporting live, high-speed, multicolor imaging with manageable data volumes.
"Life science researchers need to trust that what they see reflects what is really happening in the sample," said Evident CEO Wes Pringle. "The SilVIR-RAY detector builds on Evident's legacy of optical expertise and proven SilVIR™ technology, empowering researchers to capture fast, multicolor events in super-resolution and make decisions with quantitative confidence in their data."
The SilVIR-RAY detector is available now on new FLUOVIEW FV5000 systems and as an upgrade for existing users. It functions as a standard confocal detector when super-resolution is not needed, so labs can use one detector across a wide range of experiments.
"More than beautiful images, SilVIR-RAY provides the image quality needed for quantitative analysis. Its wide dynamic range and unique objective lens can help improve both research confidence and analytical efficiency," said Dr. Shigeo Okabe, director of the RIKEN Center for Brain Science (CBS) in Tokyo.
The FV5000 platform combines the new SilVIR-RAY detector with 2K resonant and 8K galvo scanning, FLUOVIEW Smart™ software, the TruResolution™ automated spherical aberration correction system, and flexible configurations designed to adapt to evolving research needs. Researchers can add detectors, objectives, cameras, or lasers as workflows advance, or upgrade from confocal to multiphoton imaging on one platform.
To learn more about the FLUOVIEW FV5000 and its new SilVIR-RAY detector, visit EvidentScientific.com/FV5000.
For Research Use Only. Not for use in diagnostic procedures.
FLUOVIEW, FLUOVIEW Smart, SilVIR, SilVIR-RAY, and TruResolution are trademarks of Evident Corporation or its subsidiaries.
About EVIDENT
For over 100 years as Olympus, we set the industry standard for optical precision in microscopy, helping the world see what was once out of view. Today, as Evident, we continue to help scientists, physicians, and engineers illuminate the unseen with advanced imaging solutions that combine renowned optics with cutting-edge digital innovation.
Our life science portfolio supports research, clinical diagnostics, and education, offering a comprehensive range of imaging methods from essential brightfield and darkfield microscopy to advanced fluorescence, 4D analysis, and digital pathology. In industrial microscopy, we deliver precision and flexibility through laser scanning, digital, and semiconductor microscopes designed for tasks ranging from routine inspection to intricate quality control and manufacturing analysis.
Whether advancing new therapies, ensuring product integrity, or exploring the unknown, Evident is defining a new era of discovery with easy-to-use tools that help unlock hidden answers and empower exciting new breakthroughs.
Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China, with operations and dedicated sales and service centers around the world. For more information, visit EvidentScientific.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
EVIDENT Brings Simultaneous Four-Channel Super-Resolution Imaging to Live-Cell Research with New SilVIR-RAY™ Detector
LeBleu® and KAMIYA Make Debut in Hong Kong, Drawing Widespread Industry Attention
HONG KONG, Nov. 13, 2026 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. (referred to as "Eyebright Medical", Stock Code: 688050.SH) completed its participation in the Hong Kong International Optical Fair 2026. Held from November 4 to 6, 2026, at the Hong Kong Convention and Exhibition Centre, the fair serves as a trade event for the optometry and eyewear industry, bringing together global buyers, eye care professionals, and brand representatives as a platform for technology exchange and international channel expansion.
At this year's exhibition, Eyebright Medical presented its vision care brand portfolio. Driven by the steady growth of the group's vision care sector, the dual brands LeBleu® and KAMIYA made a simultaneous appearance, showcasing Eyebright Medical's end-to-end R&D, manufacturing, and sales capabilities to partners across the Asia-Pacific region.
As Eyebright Medical's representative brand for contact lenses, LeBleu® incorporates the group's R&D capabilities in optical design and manufacturing. Backed by Eyebright Medical's R&D team of over 300 professionals and two self-owned, GMP-certified smart manufacturing bases — Jiangsu Tianyan Medical and Fujian Evercon, with a combined standardized R&D and production space of over 120,000 square meters. LeBleu® maintains end-to-end control over material R&D, optical design, manufacturing, and quality control, safeguarding product stability and wearing safety at the source.
LeBleu® presented several product series at the fair, including silicone hydrogel series, EDF aspheric daily disposable contact lenses, EDF+ high-order aspheric bi-weekly and half-year disposable contact lenses, and Toric color contact lenses. The product line incorporates Extended Depth of Focus (EDF) aspheric optical design alongside storage solution formulations containing Vitamin B12 and Hyaluronic Acid tailored for daily wear.
Sharing the spotlight was KAMIYA, an emerging color contact lens brand, which showcased its Spotlight Series Toric Color Contact Lenses in their Hong Kong debut. As Eyebright Medical's brand in the color lens segment, KAMIYA focuses on consumer preferences for fashion aesthetics and product value. Supported by Eyebright Medical's manufacturing infrastructure and digital quality control, KAMIYA maintains batch-level product traceability. Furthermore, utilizing high-speed AOI optical inspection systems and supply chain management, KAMIYA optimizes its cost structure to deliver accessible pricing.
The sample trial sessions during the exhibition generated strong interest. Channel partners from Hong Kong, Macao, and Southeast Asia inquired about product registration, packaging localization, and market promotion strategies, evaluating the commercial potential of color lens brands among young Asia-Pacific consumers.
Eyebright Medical's participation attracted media coverage and on-site interviews. Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales Director of Eyebright Medical Technology (Beijing) Co., Ltd., together with Ms. Zhou Yuxi, General Manager of Eyebright Medical's Hong Kong subsidiary, jointly participated in media interviews and shared the group's operational developments, outlining Eyebright Medical's international growth orientation and overall business structure. The organizer, Hong Kong Trade Development Council, also highlighted Eyebright Medical as an exhibitor case study across official event communications.
As an international hub connecting Mainland China with global markets, Hong Kong serves as a strategic node for Eyebright Medical's regional roadmap. Leveraging Hong Kong's business network and regulatory framework, Eyebright Medical's local team continues to advance international registration, academic engagement, and channel development across its vision care and ophthalmic device portfolios.
About Eyebright Medical Technology (Beijing) Co., Ltd.
Eyebright Medical Technology (Beijing) Co., Ltd. is listed on the STAR Market of the Shanghai Stock Exchange (Stock Abbreviation: Eyebright Medical, Stock Code: 688050.SH). Located in Zhongguancun Science Park, Beijing, it is a National High-Tech Enterprise and a recognized National "Little Giant" Enterprise specializing in niche markets. As an innovation-driven high-end medical device manufacturer with a global vision, Eyebright Medical has strategically laid out its presence across four high-potential sectors: ophthalmic surgical treatments, myopia management, consumer vision care, and sports medicine. Leveraging deep technical barriers and robust commercialization capabilities, the company is positioning itself among global medical technology leaders as a representative of China's intelligent manufacturing strength.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026
Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026
